ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (audio)
- Author
- cancerGRACE - H. Jack West, MD
- Published
- Mon 26 Aug 2013
- Episode Link
- http://cancergrace.libsyn.com/asco-lung-cancer-highlights-part-10-strategies-after-resistance-to-crizotinib-in-alk-positive-advanced-nsclc-audio
Dr. Edward Garon, David Geffen School of Medicine at UCLA, describes the exciting developments with LDK-378 and potentially other second generation ALK inhibitors for crizotinib-resistant ALK-positive advanced NSCLC.
